Carisma Therapeutics Inc (NASDAQ:CARM)
| 6.37 Delayed Data As of Jun 02 |  +0.52 / +8.89%Today’s Change | 2.75 Today|||52-Week Range 19.30 | -47.74% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 36.1M | 25.3M | 14.7M | 50.4M | |
| Short Term Investment Cash | -18.0M | -10.7M | -10.7M | 35.8M | ||
| Cash & Short Term Investments | 36.1M | 25.3M | 14.7M | 50.4M | ||
| Receivables | Receivables | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Current Assets | Other Current Assets | 232.0K | 585.0K | 301.0K | 1.3M | |
| Current Assets | 36.3M | 25.9M | 15.0M | 51.8M | ||
| Total Assets | Property, Plant and Equipment - Gross | 2.4M | 867.0K | 853.0K | 860.0K | |
| Depreciation | -2.0M | -71.0K | -331.0K | -539.0K | ||
| Intangible Assets | -- | 77.4M | 59.5M | 59.5M | ||
| Other Assets | 13.0K | 77.4M | 59.6M | 59.5M | ||
| Total Assets | 36.8M | 104.1M | 75.1M | 111.6M | ||
| Liabilities | Accounts Payable | 1.2M | 1.7M | 907.0K | 1.4M | |
| Short Term Debt | 4.1M | 0.00 | 0.00 | 0.00 | ||
| Accrued Expenses | 1.1M | 1.4M | 3.1M | 3.4M | ||
| Other Current Liabilities | 1.6M | 2.0M | 3.1M | 3.7M | ||
| Other Liabilities | 7.6M | 4.0M | 4.7M | 6.1M | ||
| Total Liabilities | Long Term Debt | 9.8M | 0.00 | 0.00 | 0.00 | |
| Deferred Taxes | -- | -16.3M | -12.5M | -12.5M | ||
| Other Liabilities | 538.0K | 5.0K | 215.0K | 48.7M | ||
| Total Liabilities | 17.9M | 65.4M | 57.1M | 67.4M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 18.9M | 38.7M | 18.0M | 44.2M | ||
| Total Shareholder Equity | 18.9M | 38.7M | 18.0M | 44.2M | ||
| Share Information | Common Shares Outstanding | 19.6M | 24.5M | 34.7M | 77.5M | |
| Addtl. Info. | No data currently available for this section. | |||||
